-

CMP Scientific's Cutting-Edge Technology Solves CE-SDS Peak Identification Challenge

BROOKLYN, N.Y.--(BUSINESS WIRE)--CMP Scientific Corp., a leading innovator in advancing biotech analysis, has unveiled a groundbreaking method that addresses a longstanding challenge in the biotechnology industry: the accurate identification of CE-SDS peaks, essential for assessing the purity and quality of antibody therapeutics. By integrating the power of capillary zone electrophoresis-mass spectrometry (CZE-MS) with CE-SDS assays, CMP Scientific has set a new benchmark for precision, speed, and efficiency in impurity detection.

  • CMP's Technological Edge: The novel method developed by CMP Scientific excels in its ability to rapidly and accurately identify impurities in antibody production, a task that has historically been challenging and time-consuming.
  • Overcoming CE-SDS Challenges: This innovative approach has successfully addressed key difficulties in CE-SDS peak identification, providing a robust and efficient solution that simplifies the process and enhances reliability.
  • High-Resolution Separation: Leveraging the unmatched power of CZE-MS, CMP Scientific's method ensures that even trace impurities are detected and characterized with exceptional clarity and accuracy.
  • Comprehensive Solution: The method offers a holistic solution, applicable across various stages of biopharmaceutical development, from discovery to final product quality control.
  • Synergistic Approach: Combining CZE-MS and CE-SDS assays enhances detection capabilities, offering complementary insights for more comprehensive impurity profiling in antibody therapeutics.

Quote from Dr. James Xia, CEO of CMP Scientific:

"At CMP Scientific, we are committed to pushing the boundaries of what's possible in biotech analysis. Our latest breakthrough is a testament to our innovative spirit and technical prowess, offering a revolutionary solution for the accurate identification of CE-SDS peaks, which are crucial for ensuring the quality and safety of antibody therapeutics."

For more detailed information about this innovative method, please refer to the peer-reviewed article co-authored with our industry partners in a leading scientific journal. You can access the full text of the publication through the following link: https://rdcu.be/dSvhM

About CMP Scientific

CMP Scientific specializes in capillary electrophoresis coupled with electrospray mass spectrometry (CE-MS) products and technologies. The company's product portfolio includes CE-MS systems, CE-MS ion sources, CE instruments, separation capillaries, electrospray emitters, cIEF-MS reagent kits, and peripheral equipment. CMP Scientific's globally patented EMASS-II CE-MS coupling technology is recognized for its exceptional stability, sensitivity, and performance.

For more information, please visit www.cmpscientific.com.

Contacts

Joshua Wiley, PhD
Director of R&D
CMP Scientific Corp
+1 530-387-4198
Joshua.wiley@cmpscientific.com

CMP Scientific Corp.


Release Versions

Contacts

Joshua Wiley, PhD
Director of R&D
CMP Scientific Corp
+1 530-387-4198
Joshua.wiley@cmpscientific.com

More News From CMP Scientific Corp.

CMP Scientific Announces Dr. Darlene Solomon to Advise on Strategy and Technology

BROOKLYN, N.Y.--(BUSINESS WIRE)--CMP Scientific, a leader in capillary electrophoresis–mass spectrometry (CE-MS) technology, today announced the appointment of Dr. Darlene Solomon, former Chief Technology Officer and Senior Vice President of Agilent Technologies, and member of the National Academy of Engineering as external Executive Advisor of Strategy and Technology. “We are honored to welcome Dr. Solomon to CMP Scientific,” said James Xia, CEO of CMP Scientific. “Her deep expertise in techno...

CMP Scientific Launches BioSummit™ CVA System, the Next-Generation cIEF-MS Platform for Charge Variant Analysis

BROOKLYN, N.Y.--(BUSINESS WIRE)--CMP Scientific, a leader in capillary electrophoresis-mass spectrometry (CE-MS) technologies, is proud to announce the launch of its highly anticipated BioSummit™ CVA system at the 72nd ASMS Conference on Mass Spectrometry and Allied Topics. This state-of-the-art technology is set to revolutionize online charge variant analysis of recombinant protein therapeutics, offering unparalleled precision and robustness for capillary zone electrophoresis-mass spectrometry...

CMP Scientific Signs a Co-Marketing Agreement with Agilent to Advance Capillary Electrophoresis–Mass Spectrometry Solutions

BROOKLYN, N.Y.--(BUSINESS WIRE)--CMP Scientific, a leader in Capillary Electrophoresis-Mass Spectrometry (CE-MS) technologies, signed a global co-marketing agreement with Agilent....
Back to Newsroom